Tag: revance therapeutics

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management
FDA Accepts Revance Resubmission for Frown Line Treatment

All

Sorry, No Posts Found

All

Neinstein Plastic Surgery Hires Breast Specialist Anna Steve

New York City-based Neinstein Plastic Surgery announces that board-certified plastic surgeon and breast specialist Anna Steve, MD, has joined its surgical team. Her appointment is the culmination of a three-year-long global search, according to practice officials.

Nanofat Grafting Can Reverse Structural Decline of Aging Skin
Surgeons Develop Technique to Reduce Adam’s Apple Without Neck Scar
The ABCs of Abdominoplasty